Vaccines (May 2022)

Evaluation of Meningococcal Serogroup C Bactericidal Antibodies after Primary Vaccination: A Multicentre Study, Italy

  • Arianna Neri,
  • Massimo Fabiani,
  • Anna Maria Barbui,
  • Caterina Vocale,
  • Alessandro Miglietta,
  • Cecilia Fazio,
  • Anna Carannante,
  • Annapina Palmieri,
  • Paola Vacca,
  • Luigina Ambrosio,
  • Paola Stefanelli

DOI
https://doi.org/10.3390/vaccines10050778
Journal volume & issue
Vol. 10, no. 5
p. 778

Abstract

Read online

Here, we evaluated over time in different cohorts of children vaccinated against serogroup C Neisseria meningitidis, the presence of antibodies with neutralizing activity. A total of 348 sera samples of enrolled children by year since vaccination (p < 0.001). Children vaccinated with the tetravalent meningococcal serogroup ACWY vaccine resulted in a high proportion of bactericidal rSBA MenC titer ≥ 1:8 (90.6%, 95% CI: 79.3–96.9%) after a mean time of seven months. Overall, the results provide some evidences on the evaluation of meningococcal serogroup C bactericidal antibodies after primary vaccination.

Keywords